On February 14, 2013, The Hamner Institutes for Health Sciences announced its partnership with QPS Holdings, LLC, a Newark, Delaware USA headquartered contract research organization (CRO), and together the two have launched QPS Hepatic Biosciences, a center of excellence for cell based research and services.  Hepatic Biosciences is a new division within the QPS DMPK department and will specialize in hepatocyte research, drug metabolism, drug transporter sciences, and in vitro drug-drug interactions.  The scientific discipline of this new operation at The Hamner Institutes is jointly led by Drs. Edward LeCluyse, Associate Investigator at The Hamner, and Caroline Lee, Director of Drug Metabolism and Transporter Sciences at QPS.  Hepatic Biosciences has also assumed responsibility for all GLP-compliant quality assurance and bioanalysis in support of The Hamner.  In addition to augmenting existing Hamner research programs, QPS will focus on new business development for both organizations.

For more information, please refer to the press release.

Check back soon for more information on services provided by QPS Hepatic Biosciences.